Marpai Announces $12 Million Private Placement led by Mitchell Companies

Marpai, Inc., a prominent player in the healthcare technology sector, has successfully raised $12 million through a private placement of newly designated convertible preferred stock. The funding round, which was led by Mitchell Companies, was announced on July 29, 2026. This investment aims to bolster Marpai's growth and enhance its technology-enabled healthcare services platform, furthering its mission to provide innovative healthcare administration solutions.

Founded to address the complexities of Third-Party Administration (TPA) and Pharmacy Benefit Management (PBM) services, Marpai focuses on empowering self-funded employers to optimize their health plans and reduce costs. By leveraging advanced, data-driven technology, the company aims to deliver a transparent and efficient benefits experience for employers, members, and healthcare partners. The recent capital infusion will enable Marpai to accelerate its strategic initiatives, including expanding its technology roadmap and scaling operations to meet increasing market demand.

Mitchell Companies, a family office and investment platform, is known for its strategic investments in high-growth businesses across various sectors, including healthcare. The firm’s involvement in this funding round underscores its commitment to supporting companies with strong leadership and scalable operational frameworks. The leadership team at Marpai, led by CEO Damien Lamendola, has been recognized for its vision and operational expertise, positioning the company for significant growth in the evolving healthcare landscape.

The healthcare technology sector is experiencing rapid transformation, driven by the need for more efficient and cost-effective solutions in healthcare administration. As employers increasingly seek to manage healthcare expenditures while improving outcomes for their employees, companies like Marpai are well-positioned to capture market share. The investment from Mitchell Companies not only provides the necessary capital but also aligns with the strategic vision of enhancing healthcare services through technology.

Looking ahead, the successful fundraising will likely serve as a catalyst for Marpai as it navigates the competitive healthcare technology landscape. The company’s strengthened financial position and commitment to innovation could enable it to capitalize on emerging opportunities, ultimately delivering enhanced value to its clients. As the sector continues to evolve, the implications of this investment may resonate beyond Marpai, influencing trends and investment strategies within the broader healthcare technology market.